DAVID MAKI

Profile

First Name

: DAVID

Middle Name

:

Last Name

: MAKI

Related Companies
Titles
Company Name
Related People
DIRECTOR
PULMATRIX INC
ROBERT CLARKE, ROBERT CONNELLY, ROBERT T CONNELLY, ROBERT T. CONNELLY, DAVID EDWARDS, MARK GABRIELSON, STEVEN GILLIS, KURT GRAVES, DAVID HAVA, MICHAEL HIGGINS, TERRANCE MCGUIRE, TERRY MCGUIRE, SCOTT ROCKLAGE, LAUREN SILVERMAN
DIRECTOR
PULMATRIX OPERATING COMPANY, INC.
ROBERT CLARKE, ROBERT CONNELLY, ROBERT T CONNELLY, ROBERT T. CONNELLY, DAVID EDWARDS, MARK GABRIELSON, STEVEN GILLIS, KURT GRAVES, DAVID HAVA, MICHAEL HIGGINS, TERRANCE MCGUIRE, TERRY MCGUIRE, SCOTT ROCKLAGE, LAUREN SILVERMAN
DIRECTOR
PULMATRIX, INC.
AKIHISA AKAO, HOJABR ALIMI, RICHARD BATYCKY, TODD BAZEMORE, CHRISTOPHER CABELL, ROBERT CLARKE, RICHARD CONLEY, WILLIAM DUKE, GREGORY FRENCH, STEVEN GILLIS, KURT GRAVES, SAMEER HARISH, DAVID HAVA, MICHAEL HIGGINS, MICHAEL J. HIGGINS, MARK IWICKI, PETER LUDLUM, TERRANCE MCGUIRE, AMIT MUNSHI, AMIT D. MUNSHI, . OCULUS INNOVATIVE SCIENCES, INC., TEOFILO RAAD, JAMES ROACH, SCOTT ROCKLAGE, MATTHEW SHERMAN, MICHELLE S. SIEGERT, ANAND VARADAN
DIRECTOR
ALTITUDE LIFE SCIENCE VENTURES SIDE FUND II, L.P.
N/A ALTITUDE LIFE SCIENCE VENTURES II, LLC, N/A ALTITUDE VENTURES MANAGEMENT, LLC
DIRECTOR
EFFECTOR THERAPEUTICS, INC.
JEREMY BARTON, M.D., CAROL G. GALLAGHER, PHARM.D., SIMEON GEORGE, SIMEON J. GEORGE, M.D., MARKUS GOEBEL, MARKUS GOEBEL, M.D., PH.D., KEN HAAS, KENNETH HAAS, J.D., ELAINE JONES, PH.D., MAHA KATABI, MAHA KATABI, PH.D., STEFAN LARSON, PH.D., LAURENCE LASKY, LAURENCE LASKY, PH.D., DAVID MAKI, J.D., ALANA MCNULTY, DENIS PATRICK, PH.D., JONATHAN ROOT, JONATHAN D. ROOT, M.D., JOHN W. SMITHER, STEPHEN F. WORLAND, PH.D., STEPHEN T. WORLAND, PH.D.
EXECUTIVE OFFICER
HDP I REIT LLC
GREGORY S. LEADHOLM, MAURY R. TOGNARELLI
EXECUTIVE OFFICER
HEITMAN CORE REAL ESTATE DEBT INCOME TRUST, L.P.
JERRY CLAEYS, PETE FAWCETT, LEWIS S. INGALL, GREG LEADHOLM, GREGORY S. LEADHOLM, MARY LUDGIN, MAURY R. TOGNARELLI
EXECUTIVE OFFICER
HEITMAN CREDIT REIT, LLC
LAWRENCE J. CHRISTENSEN, HOWARD J. EDELMAN, [ENTITY] HEITMAN CORE REAL ESTATE DEBT INCOME TRUST, L.P., LEWIS INGALL, GREGORY S. LEADHOLM, MAURY R. TOGNARELLI
DIRECTOR
ALTITUDE LIFE SCIENCE VENTURES SIDE FUND III, L.P.
N/A ALTITUDE LIFE SCIENCE VENTURES III, LLC, N/A ALTITUDE VENTURES MANAGEMENT, LLC
EXECUTIVE OFFICER
APFC HCF HOLDINGS REIT LLC
LAWRENCE J. CHRISTENSEN, [ENTITY] HEITMAN CAPITAL MANAGEMENT LLC, THOMAS P. KELLY, JONATHAN LINDELL, THOMAS D. MCCARTHY, PASCAL SOUVENIR, MAURY R. TOGNARELLI, CAROLINE VASQUEZ-HURMAN, SUSAN WHELIHAN
EXECUTIVE OFFICER
HEITMAN GLOBAL REAL ESTATE REIT LLC
GORDON BLACK, YUNJUNG CHOI, LAWRENCE CHRISTENSEN, DWIGHT FAWCETT, N/A HEITMAN GLOBAL REAL ESTATE HOLDINGS, L.P., N/A HEITMAN GLOBAL REAL ESTATE PARTNERS GP, LLC, LEWIS INGALL, BLAISE KEANE, GREGORY LEADHOLM, MARY LUDGIN, THOMAS MCCARTHY, HAROLD SCHWARTZ, TONY SMEDLEY, MAURY TOGNARELLI
EXECUTIVE OFFICER
HEITMAN REAL ESTATE DEBT PARTNERS III, L.P.
JEFFREY BINGHAM, LAWRENCE J. CHRISTENSEN, PETE K. FAWCETT, LEWIS R. INGALL, GREGORY S. LEADHOLM, JONATHAN LINDELL, MARY K. LUDGIN, THOMAS D. MCCARTHY, MAURY R. TOGNARELLI
EXECUTIVE OFFICER
HEITMAN REAL ESTATE DEBT PARTNERS III-A, L.P.
JEFFREY BINGHAM, LAWRENCE J. CHRISTENSEN, PETE K. FAWCETT, LEWIS R. INGALL, GREGORY S. LEADHOLM, JONATHAN LINDELL, MARY K. LUDGIN, THOMAS D. MCCARTHY, MAURY R. TOGNARELLI
EXECUTIVE OFFICER
HEITMAN REAL ESTATE DEBT PARTNERS III-BLOCKER, L.P.
JEFFREY BINGHAM, LAWRENCE J. CHRISTENSEN, PETE K. FAWCETT, LEWIS R. INGALL, GREGORY S. LEADHOLM, JONATHAN LINDELL, MARY K. LUDGIN, THOMAS D. MCCARTHY, MAURY R. TOGNARELLI
EXECUTIVE OFFICER
HDP III REIT INVESTMENTS LLC
LAWRENCE J. CHRISTENSEN, DWIGHT P. FAWCETT, LEWIS S. INGALL, GREGORY S. LEADHOLM, JONATHAN LINDELL, THOMAS D. MCCARTHY, MAURY R. TOGNARELLI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-02-03
D/A
Link
OTHER INVESTMENT FUND 
 
 
 
2023-12-19 
2025-02-03
D/A
Link
OTHER INVESTMENT FUND 
 
 
 
2023-12-19 
2025-02-03
D/A
Link
OTHER INVESTMENT FUND 
 
 
 
2023-12-19 
2024-12-27
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2024-12-19 
2024-07-29
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2024-01-03
D
Link
OTHER INVESTMENT FUND 
 
 
 
2023-12-19 
2024-01-03
D
Link
OTHER INVESTMENT FUND 
 
 
 
2023-12-19 
2024-01-03
D
Link
OTHER INVESTMENT FUND 
 
 
 
2023-12-19 
2023-07-28
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2022-07-29
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2022-02-09
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-27 
2021-08-06
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2020-08-06
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2020-06-26
D/A
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2015-06-11 
2019-08-06
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2019-01-28
D
Link
 
 
DECLINE TO DISCLOSE 
 
2019-01-25 
2019-01-22
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2019-01-16 
2018-08-06
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2017-12-29
D
Link
 
 
DECLINE TO DISCLOSE 
 
2017-12-22 
2017-12-21
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2017-10-18
D/A
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2017-08-03
D
Link
OTHER INVESTMENT FUND 
 
 
Equity 
2017-05-25 
2016-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-11 
2016-01-04
D
Link
REITS AND FINANCE 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-22 
2015-12-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-11 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-13 
2015-06-30
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-15 
2015-06-26
D
Link
VENTURE CAPITAL FUND 
 
DECLINE TO DISCLOSE 
 
2015-06-11 
2013-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02 
2012-10-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02 
2011-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-08-02